MapLight Therapeutics, Inc. (MPLT)
6.92
+0.70
(+11.25%)
USD |
NASDAQ |
Nov 06, 16:00
6.92
0.00 (0.00%)
After-Hours: 16:37
MapLight Therapeutics Net Income (TTM) : -229.83M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -229.83M |
| March 31, 2026 | -199.48M |
| December 31, 2025 | -161.15M |
| Date | Value |
|---|---|
| September 30, 2025 | -100.00M |
| June 30, 2025 | -89.52M |
| March 31, 2025 | -71.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cullinan Therapeutics, Inc. | -204.69M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |